High quality drive solutions from ATLANTA AntriebssystemeE

ATLANTA AntriebssystemeE is a supplier of supplier of high-quality drive systems. It offers appropriate solution for every requirement.

TOX presents latest metal joining systems

Founded in 1978, TOX® PRESSOTECHNIK is a market leader in the field of metal joining systems without supplementary materials and without thermal influences.

German Pavillion at CIMT 2015

German companies will showcase their high-tech capabilities at CIMT 2015 in Beijing on April 20-25, 2015.

Global food encapsulation market to hit $5,464.6 Mn by 2020

Rising demand for natural flavours and clean label products will be a major growth driver

Clariant opens new desiccant facility in China

The plant in Zhengjiang will produce Container Dri II and will be part of the company’s global network for desiccant manufacturing

Mouvex unveils addition to A series eccentric disc pumps

The A6 model will replace existing Mouvex AF O pumps and features differential pressures up to 10 bar (145 psi)

in-cosmetics launches Korea show, expands Brazil event

The major global trade event continues to grow, with a 20% increase in visitors expected this year

Seasonality trend defining beauty market landscape

A new research from Mintel reveals changes in the season are influencing the development of beauty and personal care products

Bayer introduces new polymer for transparent sun protection

The Baycusan C 2000 ethanol-based polyurethane film former, which delivers high SPF yet feels good on the skin, will be launched at in-cosmetics Barcelona from April 14 to 16

Shiseido builds new innovation hub in Japan

The Global Innovation Center to be set up in Yokohama Minato Mirai 21 District will start operations by end-2018

Elopak adopts AVT’s SpectraLab at Dutch facility

The packaging company installs on-press module for inline color measurement and process control for color consistency and repeatability

Breast and ovarian cancer risk may differ by type of mutation

Findings may have implications for risk assessment and cancer prevention decision making among carriers of  BRCA1, BRCA2 mutations, according to a study published in JAMA